<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-140270" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Retinal Vascular Anomalies (VHL, Cavernous Hemangioma, Wyburn-Mason)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Senthamizh </surname>
            <given-names>Tharini</given-names>
          </name>
          <aff>Sri Lakshmi Narayana Institute of Medical Sciences,Pondicherry</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tripathy</surname>
            <given-names>Koushik</given-names>
          </name>
          <aff>ASG Eye Hospital, BT Road, Kolkata, India</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Tharini Senthamizh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Koushik Tripathy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>2</day>
          <month>5</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-140270.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Retinal vascular anomalies are rare hereditary or sporadic conditions affecting the retina and multiple organ systems. These anomalies&#x000a0;include vascular tumors and telangiectasias. The vascular tumors of the retina are retinal capillary hemangiomas,&#x000a0;cavernous hemangiomas, racemose hemangiomas, and retinal vasoproliferative tumors. The retinal telangiectasias are observed in conditions such as Coats disease, Leber's miliary aneurysms, and idiopathic juxtafoveal telangiectasias.<xref ref-type="bibr" rid="article-140270.r1">[1]</xref></p>
        <p>Capillary hemangiomas of the retina were first reported by Vigla in 1864 in a patient with central nervous system (CNS) lesions.<xref ref-type="bibr" rid="article-140270.r2">[2]</xref>&#x000a0;Retinal capillary hemangiomas&#x000a0;are benign vascular tumors originating from the neurosensory retina or optic disc.&#x000a0;These tumors are sporadic or associated with Von Hippel-Lindau (VHL) syndrome.<xref ref-type="bibr" rid="article-140270.r3">[3]</xref>&#x000a0;VHL syndrome is an inherited autosomal dominant disorder characterized by vascular tumors and cysts in multiple organ systems.<xref ref-type="bibr" rid="article-140270.r4">[4]</xref> Conditions associated with VHL syndrome include&#x000a0;CNS and retinal hemangioblastomas, renal cell carcinoma,&#x000a0;pheochromocytoma, pancreatic islet tumors, endolymphatic sac tumors, and epididymal, renal, and pancreatic cystadenomas.<xref ref-type="bibr" rid="article-140270.r5">[5]</xref><xref ref-type="bibr" rid="article-140270.r6">[6]</xref>&#x000a0;The retinal tumors typically present as a reddish-orange mass in the retinal periphery, supplied by a pair of dilated and tortuous vessels.<xref ref-type="bibr" rid="article-140270.r7">[7]</xref>&#x000a0;Vision loss is due to retinal exudation, detachment, vitreous hemorrhage, and neovascular glaucoma.<xref ref-type="bibr" rid="article-140270.r8">[8]</xref></p>
        <p>Cavernous hemangiomas&#x000a0;of the retina, also&#x000a0;known as retinal cavernomas, were initially described as angiomatosis retinae by Niccol and Moore in 1934.<xref ref-type="bibr" rid="article-140270.r9">[9]</xref><xref ref-type="bibr" rid="article-140270.r10">[10]</xref>&#x000a0;These hemangiomas&#x000a0;are rare non-progressive retinal vascular hamartomas.&#x000a0;In some cases,&#x000a0;they may involve the CNS, which can cause significant morbidity and mortality if not diagnosed and treated early.</p>
        <p>Retinal capillary hemangiomas can manifest as a solitary lesion or part of Wyburn-Mason syndrome, also known as Bonnet-Dechaume-Blanc syndrome.<xref ref-type="bibr" rid="article-140270.r11">[11]</xref> This rare congenital disorder is sporadic and results in arteriovenous malformations (AVM) in the retina, visual pathways, and midbrain, maxilla, and mandible regions.<xref ref-type="bibr" rid="article-140270.r12">[12]</xref>&#x000a0;During ophthalmoscopic examination, dilated and tortuous vessels from the optic disc to the retinal periphery are observed.<xref ref-type="bibr" rid="article-140270.r13">[13]</xref> The visual acuity upon presentation ranges from normal to poor, depending on the associated complications.<xref ref-type="bibr" rid="article-140270.r14">[14]</xref></p>
      </sec>
      <sec id="article-140270.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>The retinal&#x000a0;capillary hemangiomas, also called retinal hemangioblastomas, may present in isolation or as a significant manifestation of VHL syndrome. Mutation in the <italic toggle="yes">VHL</italic> gene at chromosome 3p25.3 is primarily associated with this autosomal dominant syndrome.<xref ref-type="bibr" rid="article-140270.r15">[15]</xref>&#x000a0;The <italic toggle="yes">VHL</italic> gene encodes the VHL protein (pVHL) responsible for the degradation of ubiquitin-mediated hypoxia-inducible factor (HIF).<xref ref-type="bibr" rid="article-140270.r16">[16]</xref>&#x000a0;The inactivation of pVHL leads to sustained activation of HIF proteins, triggering angiogenesis and tumor formation in retinal hemangioblastomas.<xref ref-type="bibr" rid="article-140270.r17">[17]</xref></p>
        <p>Retinal&#x000a0;cavernous hemangiomas can be sporadic or inherited in an autosomal dominant form.<xref ref-type="bibr" rid="article-140270.r18">[18]</xref>&#x000a0;Familial retinal cavernomas have associated cerebral and cutaneous involvement.<xref ref-type="bibr" rid="article-140270.r19">[19]</xref>&#x000a0;In combined retinal and cerebral cavernous hemangiomas,&#x000a0;multiple cerebral cavernous malformation gene mutations, including&#x000a0;<italic toggle="yes">CCM1/KRIT1</italic>&#x000a0;at chromosome 7q21.2, <italic toggle="yes">CCM2/MGC4607</italic>&#x000a0;at chromosome 7p13, and <italic toggle="yes">CCM3/PDCD10</italic>&#x000a0;at chromosome&#x000a0;3q26.1, have been identified.<xref ref-type="bibr" rid="article-140270.r20">[20]</xref>&#x000a0;A somatic mutation in the <italic toggle="yes">PIK3CA</italic> gene at chromosome&#x000a0;3q26.32 has been reported to cause sporadic&#x000a0;cerebral cavernous malformation, also called CCM4.<xref ref-type="bibr" rid="article-140270.r21">[21]</xref></p>
        <p>Racemose hemangiomas&#x000a0;in&#x000a0;Wyburn-Mason syndrome occur due to a developmental abnormality that affects the primitive vascular mesoderm, shared by the developing optic cup and anterior neural tube.<xref ref-type="bibr" rid="article-140270.r12">[12]</xref>&#x000a0;The anterior vascular plexus is responsible for the formation of the retinal and hyaloid vessels in the eye and the vasculature of the midbrain.<xref ref-type="bibr" rid="article-140270.r22">[22]</xref></p>
      </sec>
      <sec id="article-140270.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Retinal&#x000a0;capillary hemangiomas represent the most common and often earliest manifestation of VHL syndrome.<xref ref-type="bibr" rid="article-140270.r23">[23]</xref>&#x000a0;The prevalence of retinal&#x000a0;capillary hemangiomas in VHL is reported to be up to 1 in 73,080 individuals, with a higher occurrence observed in Europeans compared to non-Europeans.<xref ref-type="bibr" rid="article-140270.r24">[24]</xref><xref ref-type="bibr" rid="article-140270.r25">[25]</xref> Patients with solitary retinal hemangiomas have a 30% to 46% chance of developing VHL at a later stage.<xref ref-type="bibr" rid="article-140270.r26">[26]</xref>&#x000a0;The mean age of diagnosis of retinal&#x000a0;capillary hemangiomas in VHL is 25 years.<xref ref-type="bibr" rid="article-140270.r27">[27]</xref>&#x000a0;Both&#x000a0;men and&#x000a0;women are equally affected. VHL-associated tumors are typically bilateral or multiple. Evidence of genetic anticipation exists; the earlier the onset, the more severe the presentation is in successive generations.<xref ref-type="bibr" rid="article-140270.r28">[28]</xref>&#x000a0;The average life expectancy of patients with VHL syndrome is between ages 40 and 52, with CNS hemangioblastomas being the primary cause of mortality.<xref ref-type="bibr" rid="article-140270.r29">[29]</xref></p>
        <p>Cavernous hemangiomas&#x000a0;of the retina are more common in White patients, with no apparent gender predilection.&#x000a0;The median age of presentation is 21.<xref ref-type="bibr" rid="article-140270.r30">[30]</xref>&#x000a0;Familial type of cavernous malformations has an autosomal dominant inheritance with high penetrance and variable expressivity.<xref ref-type="bibr" rid="article-140270.r31">[31]</xref>&#x000a0;The frequency of retinal&#x000a0;cavernous hemangiomas is estimated&#x000a0;at 5% in patients with familial cerebral cavernous hemangiomas.<xref ref-type="bibr" rid="article-140270.r10">[10]</xref></p>
        <p>The exact prevalence of&#x000a0;racemose hemangiomas&#x000a0;is not known due to their rarity.<xref ref-type="bibr" rid="article-140270.r32">[32]</xref>&#x000a0;No racial or gender preference is recognized.&#x000a0;The mean age of presentation is before the third decade of life.<xref ref-type="bibr" rid="article-140270.r22">[22]</xref>&#x000a0;Hemodynamic changes in high-flow&#x000a0;arteriovenous malformations&#x000a0;can result in intra-lesional vessel wall involution, potentially leading to retinal or choroidal ischemia and degeneration.<xref ref-type="bibr" rid="article-140270.r33">[33]</xref>&#x000a0;Minor arteriovenous malformations may remain asymptomatic and are diagnosed at a later stage.<xref ref-type="bibr" rid="article-140270.r34">[34]</xref></p>
      </sec>
      <sec id="article-140270.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>In VHL syndrome, a mutation in the <italic toggle="yes">VHL</italic> gene leads to the inactivation of pVHL.<xref ref-type="bibr" rid="article-140270.r35">[35]</xref>&#x000a0;This failure of hypoxia-inducible factor degradation creates a pseudo-hypoxia state, leading to dysregulated angiogenesis, cellular proliferation, and a shift in glycolytic metabolism, thereby promoting the formation of hemangioblastomas.<xref ref-type="bibr" rid="article-140270.r36">[36]</xref>&#x000a0;The <italic toggle="yes">VHL</italic> gene exhibits&#x000a0;3 types of mutations, each with distinct characteristics as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>The first type of mutation is a deletion or nonsense mutation, typically observed in isolated hemangioblastomas.</p>
          </list-item>
          <list-item>
            <p>The second type of mutation is a missense mutation, which is further classified into&#x000a0;3 subtypes&#x02014;type 2A, type 2B, and type 2C.&#x000a0;In type 2A, patients exhibit both hemangioblastomas and pheochromocytomas. In contrast, in type 2B, patients also present with renal cell carcinomas. Type 2C is characterized by the presence of only pheochromocytomas. Missense mutations are predominantly found in patients with retinal cavernous hemangiomas.<bold>&#x000a0;</bold></p>
          </list-item>
          <list-item>
            <p>The third type of mutation, known as type 3, is associated with polycythemia.<xref ref-type="bibr" rid="article-140270.r37">[37]</xref><xref ref-type="bibr" rid="article-140270.r38">[38]</xref></p>
          </list-item>
        </list>
        <p>Retinal&#x000a0;cavernous hemangiomas have been described as localized vascular hamartomas partly separated from the normal retinal vascular system or as congenital venous malformations with the same growth potential as VHL syndrome.<xref ref-type="bibr" rid="article-140270.r39">[39]</xref> The saccular dilatations in the hemangiomas exhibit the anatomy of normal retinal vessels, explaining the lack of exudation or hemorrhage.<xref ref-type="bibr" rid="article-140270.r40">[40]</xref>&#x000a0;</p>
        <p>Retinal hemangiomas&#x000a0;in Wyburn-Mason syndrome occur due to a developmental defect in the primitive vascular plexus.<xref ref-type="bibr" rid="article-140270.r41">[41]</xref>&#x000a0;Disturbing tissue before the seventh week of gestation can result in anomalous vessels in the eye and ipsilateral mesencephalon.<xref ref-type="bibr" rid="article-140270.r12">[12]</xref>&#x000a0;However, if the disturbance occurs after the seventh week of pregnancy, it will only affect one of the structures.<xref ref-type="bibr" rid="article-140270.r42">[42]</xref>&#x000a0;The&#x000a0;direct communication between arterial and venous systems in high-flow&#x000a0;arteriovenous malformations leads to turbulent blood flow, damage to the vessel walls, thrombosis, and vessel occlusion.<xref ref-type="bibr" rid="article-140270.r43">[43]</xref>&#x000a0;High-flow arteriovenous malformations can sometimes&#x000a0;cause edema from capillary leakage or pressure changes.<xref ref-type="bibr" rid="article-140270.r44">[44]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-140270.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histopathological examination of retinal&#x000a0;capillary hemangiomas shows the presence of unusual capillary-like channels occupying all the layers of the retina that are surrounded by foamy cells with vacuoles.<xref ref-type="bibr" rid="article-140270.r45">[45]</xref><xref ref-type="bibr" rid="article-140270.r46">[46]</xref>&#x000a0;The tumors do not have endothelial cells; some may have reactive glial proliferation at the edges of larger hemangioblastomas.&#x000a0;Chan&#x000a0;et al&#x000a0;have reported the presence of sporadic tumorlet cells in ocular VHL-associated lesions.<xref ref-type="bibr" rid="article-140270.r47">[47]</xref>&#x000a0;These cells form angio-mesenchymal islands and are frequently adjacent to small retinal vessels or within the inner retinal layers.&#x000a0;Ocular hemangioblastomas exhibit high levels of cellular markers, including CD133, erythropoietin, and erythropoietin&#x000a0;receptor.<xref ref-type="bibr" rid="article-140270.r48">[48]</xref></p>
        <p>Histopathological examination of retinal&#x000a0;cavernous hemangioma shows the presence of large-sized vascular spaces lined by normal endothelium involving all the retinal layers.&#x000a0;These vessels are surrounded by thick fibroglial septa, occasionally containing glial cells.<xref ref-type="bibr" rid="article-140270.r49">[49]</xref>&#x000a0;Upon ultrastructural examination, the vessels are lined by a continuous layer of non-fenestrated endothelial cells, which exhibit terminal bars on the luminal side and a thin, uninterrupted basal membrane.&#x000a0;The basal membrane is further surrounded by an interrupted layer of pericytes encased by their basal membrane.<xref ref-type="bibr" rid="article-140270.r40">[40]</xref></p>
        <p>Retinal hemangiomas have a lack of histopathological data.&#x000a0;Distinguishing&#x000a0;between arteries and veins is complex, and the lesions occupy the entire retina thickness. The abnormal vessels are made of fibromuscular media and acellular adventitious sheath.<xref ref-type="bibr" rid="article-140270.r34">[34]</xref></p>
      </sec>
      <sec id="article-140270.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The presentation&#x000a0;of retinal&#x000a0;capillary hemangiomas depends on the size and location of the tumor. Family history plays an essential role in identifying VHL syndrome. The usual complaint is progressive vision loss.<xref ref-type="bibr" rid="article-140270.r13">[13]</xref>&#x000a0;Cerebellar hemangioblastomas may present with headache, vomiting, ataxia, and sensory and motor deficits.<xref ref-type="bibr" rid="article-140270.r50">[50]</xref>&#x000a0;Endolymphatic sac tumors are rare and typically present with symptoms such as aural fullness, disequilibrium, and hearing loss.&#x000a0;Pancreatic and renal cysts are&#x000a0;typically asymptomatic.<xref ref-type="bibr" rid="article-140270.r51">[51]</xref>&#x000a0;Patients with adrenal pheochromocytomas present with sweating, palpitation, hypertension, pallor, headache, or nausea.<xref ref-type="bibr" rid="article-140270.r52">[52]</xref>&#x000a0;Many&#x000a0;lesions&#x000a0;are detected incidentally on routine dilated fundus examination. Cystadenomas of the epididymis, if present bilaterally, can rarely cause infertility.<xref ref-type="bibr" rid="article-140270.r53">[53]</xref></p>
        <p>Cavernous hemangiomas&#x000a0;are usually asymptomatic but can present with a mild-to-moderate decrease in visual acuity.<xref ref-type="bibr" rid="article-140270.r54">[54]</xref>&#x000a0;CNS&#x000a0;involvement may present with headaches, seizures, and visual disturbances.<xref ref-type="bibr" rid="article-140270.r10">[10]</xref>&#x000a0;Retinal hemangiomas&#x000a0;of the eye are asymptomatic in smaller arteriovenous malformations and are incidentally detected during a routine examination.<xref ref-type="bibr" rid="article-140270.r22">[22]</xref>&#x000a0;Larger arteriovenous malformations may cause severe vision loss, and they present with vitreous hemorrhage, retinal detachment, venous occlusions, optic disc edema, and optic atrophy.<xref ref-type="bibr" rid="article-140270.r55">[55]</xref>&#x000a0;Neurological symptoms include headache, seizures, hemiparesis, cranial neuropathies, and hydrocephalus.<xref ref-type="bibr" rid="article-140270.r12">[12]</xref></p>
      </sec>
      <sec id="article-140270.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of retinal&#x000a0;capillary hemangiomas is made&#x000a0;through clinical examination.<xref ref-type="bibr" rid="article-140270.r56">[56]</xref> Dilated ophthalmoscopic examination reveals a reddish-orange mass with&#x000a0;dilated and tortuous afferent arterioles and efferent venules (see <bold>Image</bold>. Retinal Capillary Hemangioma).&#x000a0;The most common location is the mid-peripheral temporal quadrant of the retina.<xref ref-type="bibr" rid="article-140270.r57">[57]</xref>&#x000a0;However, 15% of the lesions are in the juxtapapillary or peripapillary retina.<xref ref-type="bibr" rid="article-140270.r7">[7]</xref>&#x000a0;The incipient lesions appear as small aneurysmal dilatations of retinal capillaries. The optic nerve hemangioblastomas lack the feeding artery and draining vein, as observed in retinal hemangioblastomas, and are often misdiagnosed.&#x000a0;Three&#x000a0;types of optic nerve hemangioblastomas are endophytic, exophytic, and sessile.<xref ref-type="bibr" rid="article-140270.r58">[58]</xref>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Endophytic tumors appear as round, reddish lesions projecting into the pre-papillary vitreous.</p>
          </list-item>
          <list-item>
            <p>Exophytic lesions extend from the disc margin to the sub-retinal space and appear as a yellow, nodular tumor.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Sessile types are challenging to detect as they appear as a localized thickening at the neuroretinal rim without prominent coloration.&#x000a0;Sessile hemangioblastomas&#x000a0;at the juxtapapillary retina show vascularity on optical coherence tomography angiography (OCTA).<xref ref-type="bibr" rid="article-140270.r52">[52]</xref><xref ref-type="bibr" rid="article-140270.r59">[59]</xref><xref ref-type="bibr" rid="article-140270.r60">[60]</xref></p>
          </list-item>
        </list>
        <p>Fundus fluorescein angiography (FFA) is the most important diagnostic tool due to the tumor's vascular nature<italic toggle="yes">.</italic><xref ref-type="bibr" rid="article-140270.r61">[61]</xref>&#x000a0;This&#x000a0;technique is useful in detecting subclinical pinpoint tumors as small as the width of a third-order retinal artery and in detecting leakage from the mass into the vitreous cavity and adjacent retina in patients with distant macular edema.<xref ref-type="bibr" rid="article-140270.r62">[62]</xref>&#x000a0;Ultrasonography shows an acoustically solid intraocular tumor with or without&#x000a0;surrounding subretinal fluid.<xref ref-type="bibr" rid="article-140270.r52">[52]</xref>&#x000a0;Optical coherence tomography (OCT) shows intraretinal tumors involving the entire retinal thickness and associated retinal changes such as retinal edema, hard exudates (hyperreflective lesions), and the epiretinal membrane.<xref ref-type="bibr" rid="article-140270.r63">[63]</xref> OCTA helps measure the dimensions and visualize the tumor's structure and response to treatment.<xref ref-type="bibr" rid="article-140270.r64">[64]</xref>&#x000a0;On OCTA, the lesions are bright, well-defined, and elevated, involving superficial and deeper retinal layers or surrounded by void areas in the deep capillary plexus.<xref ref-type="bibr" rid="article-140270.r65">[65]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>CNS hemangioblastomas most frequently occur in the cerebellum (60%), spinal cord (30%), and brainstem (10%) and rarely involve optic pathways and choroidal plexus (1%).&#x000a0;Magnetic resonance imaging (MRI) of the brain can show nodular lesions with adjacent cysts.</p>
          </list-item>
          <list-item>
            <p>Endolymphatic sac tumors are rare and appear as enhancing cysts in MRI.</p>
          </list-item>
          <list-item>
            <p>Renal manifestations include benign renal cysts and clear cell renal carcinomas diagnosed using MRI.</p>
          </list-item>
          <list-item>
            <p>Pheochromocytomas are found in approximately 20% of patients with VHL syndrome, and they are diagnosed by testing urinary catecholamines and plasma-free metanephrines compounded with abdominal ultrasound and MRI.</p>
          </list-item>
          <list-item>
            <p>Pancreatic manifestations, such as cysts, serous cystadenomas, and neuroendocrine tumors, are typically asymptomatic and are identified through&#x000a0;MRI.</p>
          </list-item>
          <list-item>
            <p>Epididymal cysts are found in 25% to 60% of men and can be identified by palpation. Ultrasound demonstrates a solid mass; sometimes, cystic lesions can be noted.<xref ref-type="bibr" rid="article-140270.r52">[52]</xref><xref ref-type="bibr" rid="article-140270.r66">[66]</xref><xref ref-type="bibr" rid="article-140270.r67">[67]</xref><xref ref-type="bibr" rid="article-140270.r68">[68]</xref><xref ref-type="bibr" rid="article-140270.r69">[69]</xref><xref ref-type="bibr" rid="article-140270.r70">[70]</xref></p>
          </list-item>
        </list>
        <p>Genetic testing to identify <italic toggle="yes">VHL</italic> gene mutation can benefit family members using southern blot and multiplex ligation-dependent probe amplification&#x000a0;techniques.<xref ref-type="bibr" rid="article-140270.r71">[71]</xref></p>
        <p>Cavernous vascular hemangioma&#x000a0;of the retina can be diagnosed through dilated fundoscopy. The lesions appear as demarcated dark, intraretinal grape-like clusters of dilated and saccular blood vessels along the retinal vein or on the optic disc (see&#x000a0;<bold>Image.</bold> Retinal Cavernous Hemangioma).<xref ref-type="bibr" rid="article-140270.r72">[72]</xref>&#x000a0;Aneurysms may be small and subtle or extensive, involving multiple quadrants of the retina.<xref ref-type="bibr" rid="article-140270.r73">[73]</xref>&#x000a0;These&#x000a0;aneurysms are raised above the retinal surface, with grey and white glial zones covering the surface due to prior recurrent hemorrhages.<xref ref-type="bibr" rid="article-140270.r74">[74]</xref> FFA typically shows hypofluorescence in the arterial phase with a slow appearance of fluorescein within the venous aneurysms.<xref ref-type="bibr" rid="article-140270.r32">[32]</xref>&#x000a0;Aneurysm filling is characterized by a fluorescein-erythrocyte interface. Red blood cells settle at the bottom leaving plasma on the top, creating fluorescein-blood levels.<xref ref-type="bibr" rid="article-140270.r75">[75]</xref>&#x000a0;OCT demonstrates a lobulated hyperreflective mass with clear cystic spaces.<xref ref-type="bibr" rid="article-140270.r76">[76]</xref>&#x000a0;Ultrasonography shows a well-defined, acoustically solid mass and helps detect large tumors obscured by vitreous hemorrhage.&#x000a0;Familial forms of cavernous hemangiomas are associated with cutaneous and cerebral cavernous hemangiomas.&#x000a0;Cerebral&#x000a0;cavernous hemangioma&#x000a0;presents with headaches, seizures, and transient visual disturbances. Cerebral&#x000a0;cavernous hemangiomas are<bold>&#x000a0;</bold>3 times more common in the supratentorial&#x000a0;part&#x000a0;of the brain compared to in the infratentorial part of the brain.<xref ref-type="bibr" rid="article-140270.r32">[32]</xref>&#x000a0;Brain MRI is needed to identify CNS cavernomas.<xref ref-type="bibr" rid="article-140270.r30">[30]</xref>&#x000a0;Genetic testing for <italic toggle="yes">CCM</italic> genes should be&#x000a0;completed in appropriate clinical settings in case of multiple hemangiomas or positive family history.<xref ref-type="bibr" rid="article-140270.r77">[77]</xref></p>
        <p>Ophthalmoscopic examination of&#x000a0;retinal racemose angiomas&#x000a0;shows a large, dilated, tortuous retinal artery extending from the optic disc and directly connecting to the retinal vein without any intervening capillaries (see <bold>Image</bold>. Retinal Racemose Angioma).<xref ref-type="bibr" rid="article-140270.r13">[13]</xref><xref ref-type="bibr" rid="article-140270.r78">[78]</xref>&#x000a0;Arteriovenous communications of the retina or retinal arteriovenous malformations can be classified into three groups based on their characteristics.<xref ref-type="bibr" rid="article-140270.r33">[33]</xref><xref ref-type="bibr" rid="article-140270.r79">[79]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Group 1 involves an arteriolar or abnormal capillary plexus between the retinal artery and vein.</p>
          </list-item>
          <list-item>
            <p>Group 2 involves direct arteriovenous communication without an intervening capillary plexus.&#x000a0;Type 1 and type 2 lesions typically do not involve the CNS.</p>
          </list-item>
          <list-item>
            <p>Group 3 involves arteriovenous shunts&#x000a0;with large convoluted vessels. The retinal arteries and veins cannot be differentiated. Such lesions are&#x000a0;typical of congenital retinocephalofacial vascular malformation syndrome or Wyburn Mason syndrome, with a high incidence of central nervous system lesions.<xref ref-type="bibr" rid="article-140270.r80">[80]</xref><xref ref-type="bibr" rid="article-140270.r81">[81]</xref></p>
          </list-item>
        </list>
        <p>Typically,&#x000a0;no exudation or hemorrhage is present. FFA findings show&#x000a0;rapid filling of the affected blood vessels without any leakage. OCTA is a better tool for detecting&#x000a0;the vessel of origin and resolving associated leaking macroaneurysms following treatment (focal laser).&#x000a0;Some associated macroaneurysms may have spontaneous thrombosis.<xref ref-type="bibr" rid="article-140270.r82">[82]</xref> Vascular lesions in the CNS commonly affect the midbrain and tend to occur on the same side as the affected eye.<xref ref-type="bibr" rid="article-140270.r32">[32]</xref>&#x000a0;Intracranial arteriovenous malformations are diagnosed using imaging techniques such as computed tomography (CT), MRI, and magnetic resonance angiography (MRA).</p>
      </sec>
      <sec id="article-140270.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of&#x000a0;capillary hemangiomas is decided based on the tumor location, number, size, and secondary effects. Inactive fibrotic lesions can be left untreated. Laser photocoagulation&#x000a0;is an effective treatment modality for smaller&#x000a0;capillary hemangiomas with basal diameters up to 4 mm.<xref ref-type="bibr" rid="article-140270.r83">[83]</xref>&#x000a0;Alternatively, cryotherapy can manage tumors up to 5 mm but requires multiple sessions to achieve optimal results.<xref ref-type="bibr" rid="article-140270.r84">[84]</xref>&#x000a0;However, cryotherapy can cause a transient increase in exudative or tractional vitreoretinopathy.<xref ref-type="bibr" rid="article-140270.r85">[85]</xref>&#x000a0;More extensive tumors require external beam radiotherapy, plaque brachytherapy, or proton beam therapy.<xref ref-type="bibr" rid="article-140270.r86">[86]</xref>&#x000a0;Advanced cases with exudative and tractional retinal detachment may need vitreoretinal surgery.<xref ref-type="bibr" rid="article-140270.r7">[7]</xref>&#x000a0;Surgical endoresection of the tumor can improve visual outcomes with minimal sequelae. Endodiathermy or feeder vessel ligation&#x000a0;may reduce the risk of intraoperative bleeding and provide better tumor control.<xref ref-type="bibr" rid="article-140270.r87">[87]</xref>&#x000a0;Juxtapapillary retinal hemangiomas can pose a significant challenge to treat due to their location in the papillomacular bundle.<xref ref-type="bibr" rid="article-140270.r88">[88]</xref>&#x000a0;However, verteporfin photodynamic therapy has shown promise as an effective treatment option for these lesions.<xref ref-type="bibr" rid="article-140270.r89">[89]</xref>&#x000a0;The ability to cause selective vascular occlusion with lesser damage to the optic nerve makes it a viable alternative.<xref ref-type="bibr" rid="article-140270.r90">[90]</xref>&#x000a0;</p>
        <p>The results of several case reports have suggested that combined anti-vascular endothelial growth factor (anti-VEGF) agents and&#x000a0;photodynamic&#x000a0;therapy may hold promise as a therapeutic option for certain retinal hemangiomas.<xref ref-type="bibr" rid="article-140270.r91">[91]</xref>&#x000a0;Belzutifan is a HIF-2-&#x003b1; inhibitor and is the first Food and Drug Administration (FDA)-approved systemic oral drug for VHL-associated tumors such as renal cell carcinoma, CNS hemangioblastoma, and pancreatic neuroendocrine tumors.&#x000a0;The most common adverse effects include anemia, nausea, headache, and raised blood glucose, and it is harmful in pregnancy.<xref ref-type="bibr" rid="article-140270.r92">[92]</xref>&#x000a0;Sunitinib, a tyrosine kinase inhibitor, has shown promising results in treating renal carcinomas in VHL syndrome but has not been effective in treating hemangioblastomas.<xref ref-type="bibr" rid="article-140270.r93">[93]</xref>&#x000a0;However, disease progression, fatigue, and hand-foot syndrome were noted in patients with advanced VHL disease.<xref ref-type="bibr" rid="article-140270.r94">[94]</xref>&#x000a0;Dovitinib, a tyrosine kinase inhibitor of the VEGF receptor and fibroblast growth factor, also resulted in adverse effects such as maculopapular rash, diarrhea, and fatigue.<xref ref-type="bibr" rid="article-140270.r95">[95]</xref>&#x000a0;Pazopanib has demonstrated clinical responses in renal tumors of VHL despite&#x000a0;adverse effects&#x000a0;such as diarrhea, hypertension, fatigue, and transaminitis.<xref ref-type="bibr" rid="article-140270.r96">[96]</xref>&#x000a0;</p>
        <p>Retinal&#x000a0;cavernous hemangiomas typically remain stable and asymptomatic and, therefore, do not require intervention.<xref ref-type="bibr" rid="article-140270.r30">[30]</xref>&#x000a0;Mild vitreous or retinal bleeding generally resolves spontaneously without medical intervention.<xref ref-type="bibr" rid="article-140270.r32">[32]</xref>&#x000a0;However, if the subretinal or vitreous hemorrhage is severe, cryotherapy and laser photocoagulation may be recommended as potential treatment options.<xref ref-type="bibr" rid="article-140270.r97">[97]</xref>&#x000a0;Systemic infliximab infusion has been reported to cause temporary tumor regression.<xref ref-type="bibr" rid="article-140270.r98">[98]</xref>&#x000a0;Recently,&#x000a0;photodynamic therapy has proven to be a safer option for patients with symptomatic hemangiomas.<xref ref-type="bibr" rid="article-140270.r99">[99]</xref>&#x000a0;</p>
        <p>The management approach for&#x000a0;retinal hemangiomas depends on the location of the arteriovenous malformations and the associated symptoms. Conservative management is typically recommended for asymptomatic arteriovenous malformations. However, symptomatic cases with complications, such as retinal ischemia, may necessitate laser photocoagulation, pars plana vitrectomy to address non-clearing vitreous hemorrhage, or cyclo-destructive procedures for painful blind eye caused by neovascular glaucoma.<xref ref-type="bibr" rid="article-140270.r100">[100]</xref>&#x000a0;Intracranial arteriovenous malformations can be treated with embolization.<xref ref-type="bibr" rid="article-140270.r101">[101]</xref></p>
      </sec>
      <sec id="article-140270.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of retinal&#x000a0;capillary hemangiomas&#x000a0;includes cavernous hemangiomas, retinal hemangiomas, retinal macroaneurysms, and retinal vasoproliferative tumors.</p>
        <p>Vasoproliferative tumors of the retina are benign reactive vascular proliferations secondary to retinal ischemia or injury<italic toggle="yes">.</italic>&#x000a0;This condition is typically non-familial and has no systemic association.<xref ref-type="bibr" rid="article-140270.r102">[102]</xref>&#x000a0;Most tumors are idiopathic, whereas the rest occur secondary to other ocular conditions&#x000a0;such as retinitis pigmentosa, Coats disease, uveitis, and retinal detachment.<xref ref-type="bibr" rid="article-140270.r103">[103]</xref>&#x000a0;The lesions are yellowish-red and&#x000a0;typically occur in the inferotemporal peripheral retina.<xref ref-type="bibr" rid="article-140270.r104">[104]</xref> Differentiation from capillary hemangiomas is possible due to their location&#x000a0;at the extreme periphery in the inferior retinal quadrant and the absence of prominent feeder vessels.<xref ref-type="bibr" rid="article-140270.r32">[32]</xref>&#x000a0;Management of&#x000a0;vasoproliferative tumors depends on the presence of visual disturbances and the lesion size.<italic toggle="yes">&#x000a0;</italic>The smaller and peripheral lesions require only observation. The treatment modalities include laser photocoagulation, transpupillary thermotherapy, cryotherapy, intravitreal anti-VEGF injections, or vitreoretinal surgery, depending on the complications.<xref ref-type="bibr" rid="article-140270.r105">[105]</xref></p>
        <p>Differentiating&#x000a0;cavernous hemangiomas of the retina from other idiopathic retinal telangiectasias, such as Coats disease and Leber's miliary aneurysm, is less challenging. These conditions are characterized by progressive vascular dilatation resulting in intraretinal and subretinal exudation.<xref ref-type="bibr" rid="article-140270.r13">[13]</xref>&#x000a0;The aneurysms are typically single and located along the retinal vessels adjacent to the areas of ischemia. Fluorescein angiography can assist in diagnosis by detecting early leakage from capillaries with adjacent capillary non-perfusion areas.<xref ref-type="bibr" rid="article-140270.r106">[106]</xref></p>
        <p>Retinal&#x000a0;arteriovenous malformations&#x000a0;associated with facial arteriovenous malformations should be differentiated from Sturge-Weber Syndrome if port-wine stains appear on the face or are associated with congenital glaucoma.</p>
        <p>Other differential diagnoses include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Inflammatory granuloma related to tuberculosis and sarcoidosis</p>
          </list-item>
          <list-item>
            <p>Exudative vascular anomalous complex&#x000a0;or retinal capillary macroaneurysm</p>
          </list-item>
          <list-item>
            <p>Perifoveal exudative vascular anomalous complex</p>
          </list-item>
          <list-item>
            <p>Macroaneurysm</p>
          </list-item>
          <list-item>
            <p>Congenital retinal marovessel&#x000a0;<xref ref-type="bibr" rid="article-140270.r107">[107]</xref><xref ref-type="bibr" rid="article-140270.r108">[108]</xref><xref ref-type="bibr" rid="article-140270.r109">[109]</xref><xref ref-type="bibr" rid="article-140270.r110">[110]</xref><xref ref-type="bibr" rid="article-140270.r111">[111]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-140270.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The visual prognosis of retinal&#x000a0;capillary hemangiomas depends&#x000a0;upon several factors, including the size, location, number, and amount of exudation.<xref ref-type="bibr" rid="article-140270.r101">[101]</xref>&#x000a0;Patients with multiple tumors are at a greater risk of developing new lesions and thus require more frequent follow-up.<xref ref-type="bibr" rid="article-140270.r112">[112]</xref>&#x000a0;Approximately 25% of cases may result in permanent visual loss, and roughly 20% of patients experience visual acuity of 20/100 or less in at least&#x000a0;1 eye.<xref ref-type="bibr" rid="article-140270.r57">[57]</xref>&#x000a0;The type of&#x000a0;mutations in the <italic toggle="yes">VHL</italic> gene has been found to affect the visual prognosis.<xref ref-type="bibr" rid="article-140270.r113">[113]</xref>&#x000a0;Individuals with truncated VHL proteins had lesser visual morbidity&#x000a0;compared to those with missense mutations, who developed more aggressive and multiple&#x000a0;retinal cavernous hemangiomas&#x000a0;with higher complication rates.<xref ref-type="bibr" rid="article-140270.r114">[114]</xref>&#x000a0;</p>
        <p>Retinal&#x000a0;cavernous hemangiomas are generally considered asymptomatic and non-progressive. In rare cases, vitreous hemorrhage may occur, which is&#x000a0;typically self-limiting.<xref ref-type="bibr" rid="article-140270.r32">[32]</xref>&#x000a0;However, cerebral&#x000a0;cavernous hemangiomas may result in severe complications such as seizures, intracranial hemorrhages, and even death.<xref ref-type="bibr" rid="article-140270.r18">[18]</xref>&#x000a0;Routine neuroimaging tests are recommended for early detection and management of the condition.<xref ref-type="bibr" rid="article-140270.r30">[30]</xref></p>
        <p>The prognosis of hemangiomas&#x000a0;of the retina is good unless patients develop complications&#x000a0;such as macular edema, vitreous hemorrhage, and neovascular glaucoma.<xref ref-type="bibr" rid="article-140270.r115">[115]</xref>&#x000a0;Vision loss&#x000a0;occurs due to the orbital-cranial&#x000a0;arteriovenous malformations causing compressive optic neuropathy.<xref ref-type="bibr" rid="article-140270.r116">[116]</xref>&#x000a0;Patients with intracranial arteriovenous malformations have poor outcomes after surgical resection if the lesion is located around the optic chiasma.<xref ref-type="bibr" rid="article-140270.r117">[117]</xref></p>
      </sec>
      <sec id="article-140270.s11" sec-type="Complications">
        <title>Complications</title>
        <p>The most common complication of retinal&#x000a0;capillary hemangiomas is the formation of epiretinal membrane and subretinal fluid.<xref ref-type="bibr" rid="article-140270.r37">[37]</xref>&#x000a0;Retinal exudation and proliferative gliosis are the significant causes of visual impairment in about 50% of the affected individuals.<xref ref-type="bibr" rid="article-140270.r118">[118]</xref>&#x000a0;A retrospective analysis of 18 patients revealed that eyes with tractional or exudative retinal detachment exhibited poor visual acuity at follow-up.<xref ref-type="bibr" rid="article-140270.r119">[119]</xref>&#x000a0;Visual loss in retinal&#x000a0;capillary hemangioma is due to retinal exudation, fibrovascular proliferation, rhegmatogenous or tractional retinal detachment, macular hole, and glaucoma.<xref ref-type="bibr" rid="article-140270.r8">[8]</xref></p>
        <p>Retinal&#x000a0;cavernous hemangiomas are non-progressive with minimal complications, the most common being vitreous hemorrhage.<xref ref-type="bibr" rid="article-140270.r39">[39]</xref>&#x000a0;Exudation is rare, and fibroglial tissue may develop over the tumor surface, which can cause visual impairment if the tumor is located at the macula.<xref ref-type="bibr" rid="article-140270.r40">[40]</xref><xref ref-type="bibr" rid="article-140270.r120">[120]</xref></p>
        <p>Retinal&#x000a0;arteriovenous malformations&#x000a0;in Wyburn-Mason syndrome can result in various complications, including macular edema, retinal ischemia, retinal vein occlusion, vitreous hemorrhage, and neovascular glaucoma.<xref ref-type="bibr" rid="article-140270.r121">[121]</xref>&#x000a0;Arteriovenous malformations in the maxillary and mandibular region can lead to profuse bleeding during dental or maxillofacial surgical procedures<italic toggle="yes">.</italic><xref ref-type="bibr" rid="article-140270.r122">[122]</xref></p>
      </sec>
      <sec id="article-140270.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Early detection of retinal vascular anomalies and frequent follow-up are crucial for avoiding severe complications.&#x000a0;Individuals with a proven <italic toggle="yes">VHL</italic>&#x000a0;mutation or a positive family history should undergo annual screening for blood pressure and visual, auditory, and neurological manifestations from the first year of age.&#x000a0;Urinary or blood metanephrines can be tested annually from age&#x000a0;5 to rule out pheochromocytomas.<xref ref-type="bibr" rid="article-140270.r123">[123]</xref>&#x000a0;MRI of the brain and spine and abdominal ultrasonography is recommended every&#x000a0;2 years from age 16.<xref ref-type="bibr" rid="article-140270.r51">[51]</xref>&#x000a0;In symptomatic patients, an MRI of the internal auditory canal can detect endolymphatic sac tumors.<xref ref-type="bibr" rid="article-140270.r124">[124]</xref>&#x000a0;Ocular screening should be performed every 6 to 12 months until&#x000a0;age&#x000a0;30 and yearly.<xref ref-type="bibr" rid="article-140270.r125">[125]</xref>&#x000a0;Familial forms of&#x000a0;cavernous hemangiomas of the retina are typically bilateral and associated with cutaneous and CNS hemangiomas, making it necessary to screen at-risk family members for cerebral hemangiomas with MRI brain.<xref ref-type="bibr" rid="article-140270.r74">[74]</xref></p>
      </sec>
      <sec id="article-140270.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Patients with retinal vascular anomalies should be aware of the possibility of systemic involvement and the importance of periodic screenings for ocular and systemic abnormalities. Such screenings can be crucial in detecting life-threatening conditions. Patients with a positive genetic test for <italic toggle="yes">VHL</italic> should be referred to a clinical geneticist for appropriate management, and those planning for pregnancy should receive education on fertility issues and the need for prenatal genetic testing.&#x000a0;Screening first-degree relatives of patients with multiple organ involvement is also imperative. In cases of cavernous or racemose hemangiomas, ruling&#x000a0;out cerebral involvement is essential, which can result in life-threatening intracranial hemorrhage.<xref ref-type="bibr" rid="article-140270.r126">[126]</xref> Asymptomatic lesions can be closely monitored without the need for intracranial surgeries.</p>
      </sec>
      <sec id="article-140270.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Retinal vascular anomalies are rare, but early identification and management are critical for reducing significant mortality and morbidity. A dedicated nurse can be assigned as a case manager to assist the treating&#x000a0;clinician in providing psychosocial care and ensuring that the patient attends the clinic on the scheduled appointment dates and follows the screening protocols. A supportive multi-disciplinary team comprising physicians, nurses, radiologists, neurologists, geneticists, ophthalmologists, endocrinologists, and ear-nose-throat specialists can improve care in such patients.<xref ref-type="bibr" rid="article-140270.r34">[34]</xref></p>
        <p>All healthcare professionals&#x000a0;involved in patient care should possess the clinical skills and knowledge to manage the condition and be aware of the potential complications. In addition, a strategic approach according to evidence-based guidelines is essential for the management and screening of the condition. Ethical considerations must guide decision-making for treatment, and patients should receive thorough counseling regarding the available treatment options to ensure that treatment aligns with their preferences. Effective coordination, communication, and teamwork are crucial for delivering&#x000a0;expert patient care, from screening to management.<xref ref-type="bibr" rid="article-140270.r127">[127]</xref><xref ref-type="bibr" rid="article-140270.r128">[128]</xref></p>
      </sec>
      <sec id="article-140270.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140270&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140270">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/retinal-vascular-anomalies-vhl-cavernous-hemangioma-wyburn-mason/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=140270">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/140270/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=140270">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-140270.s16">
        <fig id="article-140270.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Retinal Capillary Hemangioma. The image displays dilated vessels connected to the red hemangioblastoma, alongside scars from previous laser treatment and a newly observed lesion in the lower portion. Contributed by K Tripathy, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="rch" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-140270.s17">
        <fig id="article-140270.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Retinal Cavernous Hemangioma. The image shows grape-like vascular lesions. Contributed by&#x000a0;VR Dedhia, MD, MS, FICO, FVRS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="retinal__cavernous__hemangioma" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-140270.s18">
        <fig id="article-140270.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Retinal Racemose Angioma. The image shows a large, dilated, tortuous retinal artery extending from the optic disc and directly connecting to the retinal vein without any intervening capillaries. Ravani R, Patel C, Tripathy K. Optical coherence tomography of racemose angioma. <italic toggle="yes">Clin Case Rep.</italic> 2020;8(7):1299-1300. doi: 10.1002/ccr3.2841.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="racemose__angioma" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-140270.s19">
        <title>References</title>
        <ref id="article-140270.r1">
          <label>1</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paulbuddhe</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Shukla</surname>
                <given-names>UV</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Exudative Retinitis (Coats Disease)</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">32809517</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Venkatesh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Takkar</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Proposed Classification System for Retinal Capillary Angiomatosis.</article-title>
            <source>Ophthalmic Res</source>
            <year>2019</year>
            <volume>61</volume>
            <issue>2</issue>
            <fpage>115</fpage>
            <page-range>115-119</page-range>
            <pub-id pub-id-type="pmid">30497078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karimi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Arabi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shahraki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Safi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Von Hippel-Lindau Disease and the Eye.</article-title>
            <source>J Ophthalmic Vis Res</source>
            <year>2020</year>
            <season>Jan-Mar</season>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>78</fpage>
            <page-range>78-94</page-range>
            <pub-id pub-id-type="pmid">32095212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crespigio</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Berbel</surname>
                <given-names>LCL</given-names>
              </name>
              <name>
                <surname>Dias</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Berbel</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Pignatelli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mazzuco</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Von Hippel-Lindau disease: a single gene, several hereditary tumors.</article-title>
            <source>J Endocrinol Invest</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-31</page-range>
            <pub-id pub-id-type="pmid">28589383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsang</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Von Hippel-Lindau Disease.</article-title>
            <source>Adv Exp Med Biol</source>
            <year>2018</year>
            <volume>1085</volume>
            <fpage>201</fpage>
            <page-range>201-203</page-range>
            <pub-id pub-id-type="pmid">30578515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guan</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Yin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yi</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Clinical Syndromes and Genetic Screening Strategies of Pheochromocytoma and Paraganglioma.</article-title>
            <source>J Kidney Cancer VHL</source>
            <year>2018</year>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>14</fpage>
            <page-range>14-22</page-range>
            <pub-id pub-id-type="pmid">30613466</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khan</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Shahzad</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Iqbal</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Awan</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>QA</given-names>
              </name>
              <name>
                <surname>Saatci</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Abbass</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hussain</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hussain</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Ophthalmological Aspects of von-Hippel-Lindau Syndrome.</article-title>
            <source>Semin Ophthalmol</source>
            <year>2021</year>
            <month>Oct</month>
            <day>03</day>
            <volume>36</volume>
            <issue>7</issue>
            <fpage>531</fpage>
            <page-range>531-540</page-range>
            <pub-id pub-id-type="pmid">33780299</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chew</surname>
                <given-names>EY</given-names>
              </name>
            </person-group>
            <article-title>Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations.</article-title>
            <source>Trans Am Ophthalmol Soc</source>
            <year>2005</year>
            <volume>103</volume>
            <fpage>495</fpage>
            <page-range>495-511</page-range>
            <pub-id pub-id-type="pmid">17057815</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niccol</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>A CASE OF ANGIOMATOSIS RETINAE.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1934</year>
            <month>Aug</month>
            <volume>18</volume>
            <issue>8</issue>
            <fpage>454</fpage>
            <page-range>454-7</page-range>
            <pub-id pub-id-type="pmid">18169216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Labauge</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Krivosic</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Denier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tournier-Lasserve</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gaudric</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Frequency of retinal cavernomas in 60 patients with familial cerebral cavernomas: a clinical and genetic study.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2006</year>
            <month>Jun</month>
            <volume>124</volume>
            <issue>6</issue>
            <fpage>885</fpage>
            <page-range>885-6</page-range>
            <pub-id pub-id-type="pmid">16769843</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamauchi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tanaka-Gonome</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Adachi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Maeda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nakazawa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Racemose hemangioma complicated with macular macroaneurysm rupture.</article-title>
            <source>Am J Ophthalmol Case Rep</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>22</volume>
            <fpage>101053</fpage>
            <pub-id pub-id-type="pmid">33786403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Suh</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Alvarez</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rodesch</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lasjaunias</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Wyburn-Mason or Bonnet-Dechaume-Blanc as Cerebrofacial Arteriovenous Metameric Syndromes (CAMS). A New Concept and a New Classification.</article-title>
            <source>Interv Neuroradiol</source>
            <year>2001</year>
            <month>Mar</month>
            <day>30</day>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <page-range>5-17</page-range>
            <pub-id pub-id-type="pmid">20663326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Knutsson</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>De Benedetto</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Querques</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Del Turco</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bandello</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lattanzio</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Primitive retinal vascular abnormalities: tumors and telangiectasias.</article-title>
            <source>Ophthalmologica</source>
            <year>2012</year>
            <volume>228</volume>
            <issue>2</issue>
            <fpage>67</fpage>
            <page-range>67-77</page-range>
            <pub-id pub-id-type="pmid">22738997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pangtey</surname>
                <given-names>BPS</given-names>
              </name>
              <name>
                <surname>Kohli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ramasamy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Wyburn-Mason syndrome presenting with bilateral retinal racemose hemangioma with unilateral serous retinal detachment.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>66</volume>
            <issue>12</issue>
            <fpage>1869</fpage>
            <page-range>1869-1871</page-range>
            <pub-id pub-id-type="pmid">30451208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Richard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Beigelman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gerber</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Van Effenterre</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gaudric</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sahel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Binaghi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Kersaint-Gilly</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Houtteville</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Brunon</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>[Does hemangioblastoma exist outside von Hippel-Lindau disease?].</article-title>
            <source>Neurochirurgie</source>
            <year>1994</year>
            <volume>40</volume>
            <issue>3</issue>
            <fpage>145</fpage>
            <page-range>145-54</page-range>
            <pub-id pub-id-type="pmid">7723921</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ruppert</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Gavin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Peiris</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Ocular Manifestations of von Hippel-Lindau Disease.</article-title>
            <source>Cureus</source>
            <year>2019</year>
            <month>Aug</month>
            <day>04</day>
            <volume>11</volume>
            <issue>8</issue>
            <fpage>e5319</fpage>
            <pub-id pub-id-type="pmid">31588386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Abu-Asab</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zhuang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Chew</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Upregulation of hypoxia-inducible factors and autophagy in von Hippel-Lindau-associated retinal hemangioblastoma.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>252</volume>
            <issue>8</issue>
            <fpage>1319</fpage>
            <page-range>1319-27</page-range>
            <pub-id pub-id-type="pmid">24859386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dobyns</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Michels</surname>
                <given-names>VV</given-names>
              </name>
              <name>
                <surname>Groover</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Mokri</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Trautmann</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Forbes</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Laws</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Familial cavernous malformations of the central nervous system and retina.</article-title>
            <source>Ann Neurol</source>
            <year>1987</year>
            <month>Jun</month>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>578</fpage>
            <page-range>578-83</page-range>
            <pub-id pub-id-type="pmid">3606045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Labauge</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Enjolras</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Bonerandi</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Laberge</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dandurand</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Joujoux</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Tournier-Lasserve</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>An association between autosomal dominant cerebral cavernomas and a distinctive hyperkeratotic cutaneous vascular malformation in 4 families.</article-title>
            <source>Ann Neurol</source>
            <year>1999</year>
            <month>Feb</month>
            <volume>45</volume>
            <issue>2</issue>
            <fpage>250</fpage>
            <page-range>250-4</page-range>
            <pub-id pub-id-type="pmid">9989629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reddy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gorin</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>McCannel</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Tsui</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Straatsma</surname>
                <given-names>BR</given-names>
              </name>
            </person-group>
            <article-title>Novel KRIT1/CCM1 mutation in a patient with retinal cavernous hemangioma and cerebral cavernous malformation.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>248</volume>
            <issue>9</issue>
            <fpage>1359</fpage>
            <page-range>1359-61</page-range>
            <pub-id pub-id-type="pmid">20306072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peyre</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Miyagishima</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bielle</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chapon</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sierant</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Venot</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Lerond</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Marijon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Abi-Jaoude</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Le Van</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Labreche</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Houlston</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Faisant</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cl&#x000e9;menceau</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Boch</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Nouet</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carpentier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boetto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Louvi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kalamarides</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Somatic <italic>PIK3CA</italic> Mutations in Sporadic Cerebral Cavernous Malformations.</article-title>
            <source>N Engl J Med</source>
            <year>2021</year>
            <month>Sep</month>
            <day>09</day>
            <volume>385</volume>
            <issue>11</issue>
            <fpage>996</fpage>
            <page-range>996-1004</page-range>
            <pub-id pub-id-type="pmid">34496175</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dayani</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Sadun</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>A case report of Wyburn-Mason syndrome and review of the literature.</article-title>
            <source>Neuroradiology</source>
            <year>2007</year>
            <month>May</month>
            <volume>49</volume>
            <issue>5</issue>
            <fpage>445</fpage>
            <page-range>445-56</page-range>
            <pub-id pub-id-type="pmid">17235577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jesberg</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Hoyt</surname>
                <given-names>WF</given-names>
              </name>
            </person-group>
            <article-title>Incipient lesions of von Hippel-Lindau disease.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1968</year>
            <month>Nov</month>
            <volume>80</volume>
            <issue>5</issue>
            <fpage>632</fpage>
            <page-range>632-40</page-range>
            <pub-id pub-id-type="pmid">5693353</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Binderup</surname>
                <given-names>MLM</given-names>
              </name>
              <name>
                <surname>Stendell</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Galanakis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>M&#x000f8;ller</surname>
                <given-names>HU</given-names>
              </name>
              <name>
                <surname>Kiilgaard</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Bisgaard</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>102</volume>
            <issue>7</issue>
            <fpage>942</fpage>
            <page-range>942-947</page-range>
            <pub-id pub-id-type="pmid">28972023</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Azimi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Aghajani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Khakpour</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chaibakhsh</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A meta-analysis of different von Hippel Lindau mutations: are they related to retinal capillary hemangioblastoma?</article-title>
            <source>Mol Genet Genomics</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>297</volume>
            <issue>6</issue>
            <fpage>1615</fpage>
            <page-range>1615-1626</page-range>
            <pub-id pub-id-type="pmid">36006455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Solitary retinal capillary hemangioma: hereditary (von Hippel-Lindau disease) or nonhereditary?</article-title>
            <source>Arch Ophthalmol</source>
            <year>2001</year>
            <month>Feb</month>
            <volume>119</volume>
            <issue>2</issue>
            <fpage>232</fpage>
            <page-range>232-4</page-range>
            <pub-id pub-id-type="pmid">11176984</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maher</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Yates</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Harries</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Benjamin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Ferguson-Smith</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Clinical features and natural history of von Hippel-Lindau disease.</article-title>
            <source>Q J Med</source>
            <year>1990</year>
            <month>Nov</month>
            <volume>77</volume>
            <issue>283</issue>
            <fpage>1151</fpage>
            <page-range>1151-63</page-range>
            <pub-id pub-id-type="pmid">2274658</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ning</surname>
                <given-names>XH</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>XY</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Gong</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Telomere shortening is associated with genetic anticipation in Chinese Von Hippel-Lindau disease families.</article-title>
            <source>Cancer Res</source>
            <year>2014</year>
            <month>Jul</month>
            <day>15</day>
            <volume>74</volume>
            <issue>14</issue>
            <fpage>3802</fpage>
            <page-range>3802-9</page-range>
            <pub-id pub-id-type="pmid">24986515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lonser</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Butman</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Huntoon</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Asthagiri</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bakhtian</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Chew</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Zhuang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Linehan</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Oldfield</surname>
                <given-names>EH</given-names>
              </name>
            </person-group>
            <article-title>Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease.</article-title>
            <source>J Neurosurg</source>
            <year>2014</year>
            <month>May</month>
            <volume>120</volume>
            <issue>5</issue>
            <fpage>1055</fpage>
            <page-range>1055-62</page-range>
            <pub-id pub-id-type="pmid">24579662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>CAVERNOUS HEMANGIOMA OF THE RETINA: A Comprehensive Review of the Literature (1934-2015).</article-title>
            <source>Retina</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>611</fpage>
            <page-range>611-621</page-range>
            <pub-id pub-id-type="pmid">27820777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldberg</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Pheasant</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Cavernous hemangioma of the retina. A four-generation pedigree with neurocutaneous manifestations and an example of bilateral retinal involvement.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1979</year>
            <month>Dec</month>
            <volume>97</volume>
            <issue>12</issue>
            <fpage>2321</fpage>
            <page-range>2321-4</page-range>
            <pub-id pub-id-type="pmid">229814</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Rundle</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Rennie</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Retinal vascular tumors.</article-title>
            <source>Ophthalmol Clin North Am</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>167</fpage>
            <page-range>167-76, x</page-range>
            <pub-id pub-id-type="pmid">15763202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Archer</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Deutman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ernest</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Krill</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Arteriovenous communications of the retina.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1973</year>
            <month>Feb</month>
            <volume>75</volume>
            <issue>2</issue>
            <fpage>224</fpage>
            <page-range>224-41</page-range>
            <pub-id pub-id-type="pmid">4697179</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r34">
          <label>34</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>So</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Holman</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <chapter-title>Wyburn-Mason Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>26</day>
            <pub-id pub-id-type="pmid">29630270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maxwell</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Wiesener</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Clifford</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Vaux</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Cockman</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Wykoff</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Pugh</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Maher</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Ratcliffe</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.</article-title>
            <source>Nature</source>
            <year>1999</year>
            <month>May</month>
            <day>20</day>
            <volume>399</volume>
            <issue>6733</issue>
            <fpage>271</fpage>
            <page-range>271-5</page-range>
            <pub-id pub-id-type="pmid">10353251</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singer</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Bratslavsky</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Middelton</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Srinivasan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Linehan</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Impact of genetics on the diagnosis and treatment of renal cancer.</article-title>
            <source>Curr Urol Rep</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-55</page-range>
            <pub-id pub-id-type="pmid">21128028</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dollfus</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Massin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Taupin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nemeth</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Amara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Giraud</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>B&#x000e9;roud</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dureau</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gaudric</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Landais</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Richard</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>43</volume>
            <issue>9</issue>
            <fpage>3067</fpage>
            <page-range>3067-74</page-range>
            <pub-id pub-id-type="pmid">12202531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Calzada</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Von Hippel-Lindau syndrome: molecular mechanisms of the disease.</article-title>
            <source>Clin Transl Oncol</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>160</fpage>
            <page-range>160-5</page-range>
            <pub-id pub-id-type="pmid">20231120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gass</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Cavernous hemangioma of the retina. A neuro-oculo-cutaneous syndrome.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1971</year>
            <month>Apr</month>
            <volume>71</volume>
            <issue>4</issue>
            <fpage>799</fpage>
            <page-range>799-814</page-range>
            <pub-id pub-id-type="pmid">5553009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Messmer</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Font</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Laqua</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>H&#x000f6;pping</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Naumann</surname>
                <given-names>GO</given-names>
              </name>
            </person-group>
            <article-title>Cavernous hemangioma of the retina. Immunohistochemical and ultrastructural observations.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1984</year>
            <month>Mar</month>
            <volume>102</volume>
            <issue>3</issue>
            <fpage>413</fpage>
            <page-range>413-8</page-range>
            <pub-id pub-id-type="pmid">6538410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Risau</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of angiogenesis.</article-title>
            <source>Nature</source>
            <year>1997</year>
            <month>Apr</month>
            <day>17</day>
            <volume>386</volume>
            <issue>6626</issue>
            <fpage>671</fpage>
            <page-range>671-4</page-range>
            <pub-id pub-id-type="pmid">9109485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ponce</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Spetzler</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Canady</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Feiz-Erfan</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Associated arteriovenous malformation of the orbit and brain: a case of Wyburn-Mason syndrome without retinal involvement. Case report.</article-title>
            <source>J Neurosurg</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>95</volume>
            <issue>2</issue>
            <fpage>346</fpage>
            <page-range>346-9</page-range>
            <pub-id pub-id-type="pmid">11780909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schatz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Ober</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>RN</given-names>
              </name>
            </person-group>
            <article-title>Central retinal vein occlusion associated with retinal arteriovenous malformation.</article-title>
            <source>Ophthalmology</source>
            <year>1993</year>
            <month>Jan</month>
            <volume>100</volume>
            <issue>1</issue>
            <fpage>24</fpage>
            <page-range>24-30</page-range>
            <pub-id pub-id-type="pmid">8433820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Onder</surname>
                <given-names>HI</given-names>
              </name>
              <name>
                <surname>Alisan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tunc</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Serous retinal detachment and cystoid macular edema in a patient with Wyburn-Mason syndrome.</article-title>
            <source>Semin Ophthalmol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>154</fpage>
            <page-range>154-6</page-range>
            <pub-id pub-id-type="pmid">24171831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Zhuang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Hackett</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chew</surname>
                <given-names>EY</given-names>
              </name>
            </person-group>
            <article-title>Von Hippel-Lindau gene deletion and expression of hypoxia-inducible factor and ubiquitin in optic nerve hemangioma.</article-title>
            <source>Trans Am Ophthalmol Soc</source>
            <year>2004</year>
            <volume>102</volume>
            <fpage>75</fpage>
            <page-range>75-9; discussion 79-81</page-range>
            <pub-id pub-id-type="pmid">15747747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grossniklaus</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Vigneswaran</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Jarrett</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Retinal hemangioblastoma. A histologic, immunohistochemical, and ultrastructural evaluation.</article-title>
            <source>Ophthalmology</source>
            <year>1992</year>
            <month>Jan</month>
            <volume>99</volume>
            <issue>1</issue>
            <fpage>140</fpage>
            <page-range>140-5</page-range>
            <pub-id pub-id-type="pmid">1741127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vortmeyer</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Chew</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Matteson</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Wellmann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Weil</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zhuang</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Morphologic and genetic analysis of retinal angioma associated with massive gliosis in a patient with von Hippel-Lindau disease.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>1999</year>
            <month>Jun</month>
            <volume>237</volume>
            <issue>6</issue>
            <fpage>513</fpage>
            <page-range>513-7</page-range>
            <pub-id pub-id-type="pmid">10379614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Chew</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hackett</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhuang</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Expression of stem cells markers in ocular hemangioblastoma associated with von Hippel-Lindau (VHL) disease.</article-title>
            <source>Mol Vis</source>
            <year>2005</year>
            <month>Sep</month>
            <day>01</day>
            <volume>11</volume>
            <fpage>697</fpage>
            <page-range>697-704</page-range>
            <pub-id pub-id-type="pmid">16163267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pierro</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Guarisco</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zaganelli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Freschi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brancato</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Capillary and cavernous hemangioma of the optic disc. Echographic and histological findings.</article-title>
            <source>Acta Ophthalmol Suppl (1985)</source>
            <year>1992</year>
            <issue>204</issue>
            <fpage>102</fpage>
            <page-range>102-6</page-range>
            <pub-id pub-id-type="pmid">1332383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jagannathan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lonser</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>DeVroom</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Oldfield</surname>
                <given-names>EH</given-names>
              </name>
            </person-group>
            <article-title>Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease.</article-title>
            <source>J Neurosurg</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>108</volume>
            <issue>2</issue>
            <fpage>210</fpage>
            <page-range>210-22</page-range>
            <pub-id pub-id-type="pmid">18240914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Findeis-Hosey</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>McMahon</surname>
                <given-names>KQ</given-names>
              </name>
              <name>
                <surname>Findeis</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Von Hippel-Lindau Disease.</article-title>
            <source>J Pediatr Genet</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>116</fpage>
            <page-range>116-23</page-range>
            <pub-id pub-id-type="pmid">27617152</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aronow</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Wiley</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Gaudric</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Krivosic</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gorin</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Jonasch</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Chew</surname>
                <given-names>EY</given-names>
              </name>
            </person-group>
            <article-title>VON HIPPEL-LINDAU DISEASE: Update on Pathogenesis and Systemic Aspects.</article-title>
            <source>Retina</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>39</volume>
            <issue>12</issue>
            <fpage>2243</fpage>
            <page-range>2243-2253</page-range>
            <pub-id pub-id-type="pmid">31095066</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r53">
          <label>53</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>van Leeuwaarde</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>van Nesselrooij</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zandee</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Giles</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <chapter-title>Von Hippel-Lindau Syndrome</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2000</year>
            <month>5</month>
            <day>17</day>
            <pub-id pub-id-type="pmid">20301636</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Laey</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Hanssens</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brabant</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Decq</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>De Gersem</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hoste</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Huyghe</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lenaerts</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Leys</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pollet</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Vascular tumors and malformations of the ocular fundus.</article-title>
            <source>Bull Soc Belge Ophtalmol</source>
            <year>1990</year>
            <volume>225 Pt 1</volume>
            <fpage>1</fpage>
            <page-range>1-241</page-range>
            <pub-id pub-id-type="pmid">2128617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mansour</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Wells</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Jampol</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Kalina</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Ocular complications of arteriovenous communications of the retina.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1989</year>
            <month>Feb</month>
            <volume>107</volume>
            <issue>2</issue>
            <fpage>232</fpage>
            <page-range>232-6</page-range>
            <pub-id pub-id-type="pmid">2644928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>YR</given-names>
              </name>
            </person-group>
            <article-title>Retinal vascular lesions.</article-title>
            <source>J Paediatr Child Health</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>53</volume>
            <issue>1</issue>
            <fpage>89</fpage>
            <pub-id pub-id-type="pmid">28070944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Webster</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Maher</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>117</volume>
            <issue>3</issue>
            <fpage>371</fpage>
            <page-range>371-8</page-range>
            <pub-id pub-id-type="pmid">10088816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gass</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Braunstein</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Sessile and exophytic capillary angiomas of the juxtapapillary retina and optic nerve head.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1980</year>
            <month>Oct</month>
            <volume>98</volume>
            <issue>10</issue>
            <fpage>1790</fpage>
            <page-range>1790-7</page-range>
            <pub-id pub-id-type="pmid">7425905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Augsburger</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Classification and management of hereditary retinal angiomas.</article-title>
            <source>Int Ophthalmol</source>
            <year>1981</year>
            <month>Aug</month>
            <volume>4</volume>
            <issue>1-2</issue>
            <fpage>93</fpage>
            <page-range>93-106</page-range>
            <pub-id pub-id-type="pmid">7298262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Custo Greig</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Duker</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Retinal hemangioblastoma vascular detail elucidated on swept source optical coherence tomography angiography.</article-title>
            <source>Am J Ophthalmol Case Rep</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>21</volume>
            <fpage>101005</fpage>
            <pub-id pub-id-type="pmid">33385098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r61">
          <label>61</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ruia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Fluorescein Angiography</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">35015403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sagar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rajesh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shanmugam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Konana</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Comparison of optical coherence tomography angiography and fundus fluorescein angiography features of retinal capillary hemangioblastoma.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>66</volume>
            <issue>6</issue>
            <fpage>872</fpage>
            <page-range>872-876</page-range>
            <pub-id pub-id-type="pmid">29786009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heimann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jmor</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Damato</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Imaging of retinal and choroidal vascular tumours.</article-title>
            <source>Eye (Lond)</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>208</fpage>
            <page-range>208-16</page-range>
            <pub-id pub-id-type="pmid">23196648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sagar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shanmugam</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Konana</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Ramanjulu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>KCD</given-names>
              </name>
              <name>
                <surname>Simakurthy</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Optical coherence tomography angiography in assessment of response to therapy in retinal capillary hemangioblastoma and diffuse choroidal hemangioma.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2019</year>
            <month>May</month>
            <volume>67</volume>
            <issue>5</issue>
            <fpage>701</fpage>
            <page-range>701-703</page-range>
            <pub-id pub-id-type="pmid">31007251</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Paula</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abdolrahimzadeh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fragiotta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Di Pippo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Scuderi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Current concepts on ocular vascular abnormalities in the phakomatoses.</article-title>
            <source>Semin Ophthalmol</source>
            <year>2021</year>
            <month>Oct</month>
            <day>03</day>
            <volume>36</volume>
            <issue>7</issue>
            <fpage>549</fpage>
            <page-range>549-560</page-range>
            <pub-id pub-id-type="pmid">33755531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wanebo</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Lonser</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Glenn</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Oldfield</surname>
                <given-names>EH</given-names>
              </name>
            </person-group>
            <article-title>The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.</article-title>
            <source>J Neurosurg</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>98</volume>
            <issue>1</issue>
            <fpage>82</fpage>
            <page-range>82-94</page-range>
            <pub-id pub-id-type="pmid">12546356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmid</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gillessen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Binet</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Br&#x000e4;ndle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Engeler</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Greiner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hader</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Heinimann</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kloos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Krek</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Krull</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Stoeckli</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Sulz</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>van Leyen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rothermundt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hundsberger</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Management of von hippel-lindau disease: an interdisciplinary review.</article-title>
            <source>Oncol Res Treat</source>
            <year>2014</year>
            <volume>37</volume>
            <issue>12</issue>
            <fpage>761</fpage>
            <page-range>761-71</page-range>
            <pub-id pub-id-type="pmid">25531723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gl&#x000e4;sker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vergauwen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Kutikov</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vortmeyer</surname>
                <given-names>AO</given-names>
              </name>
            </person-group>
            <article-title>Von Hippel-Lindau Disease: Current Challenges and Future Prospects.</article-title>
            <source>Onco Targets Ther</source>
            <year>2020</year>
            <volume>13</volume>
            <fpage>5669</fpage>
            <page-range>5669-5690</page-range>
            <pub-id pub-id-type="pmid">32606780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shanbhogue</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Hoch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fatterpaker</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chandarana</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>von Hippel-Lindau Disease: Review of Genetics and Imaging.</article-title>
            <source>Radiol Clin North Am</source>
            <year>2016</year>
            <month>May</month>
            <volume>54</volume>
            <issue>3</issue>
            <fpage>409</fpage>
            <page-range>409-22</page-range>
            <pub-id pub-id-type="pmid">27153780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choyke</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Glenn</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Walther</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Patronas</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Linehan</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Zbar</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>von Hippel-Lindau disease: genetic, clinical, and imaging features.</article-title>
            <source>Radiology</source>
            <year>1995</year>
            <month>Mar</month>
            <volume>194</volume>
            <issue>3</issue>
            <fpage>629</fpage>
            <page-range>629-42</page-range>
            <pub-id pub-id-type="pmid">7862955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Binderup</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Bisgaard</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Harbud</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>M&#x000f8;ller</surname>
                <given-names>HU</given-names>
              </name>
              <name>
                <surname>Gimsing</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Friis-Hansen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>Tv</given-names>
              </name>
              <name>
                <surname>Bagi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Knigge</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kosteljanetz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>B&#x000f8;geskov</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thomsen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gerdes</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ousager</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Sunde</surname>
                <given-names>L</given-names>
              </name>
              <collab>Danish vHL Coordination Group</collab>
            </person-group>
            <article-title>Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition.</article-title>
            <source>Dan Med J</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>60</volume>
            <issue>12</issue>
            <fpage>B4763</fpage>
            <pub-id pub-id-type="pmid">24355456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Ewing</surname>
                <given-names>MQ</given-names>
              </name>
              <name>
                <surname>Lally</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Retinal cavernous hemangioma: fifty-two years of clinical follow-up with clinicopathologic correlation.</article-title>
            <source>Retina</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>34</volume>
            <issue>6</issue>
            <fpage>1253</fpage>
            <page-range>1253-7</page-range>
            <pub-id pub-id-type="pmid">24849703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>New Interpretation of Multimodality Fundus Imaging for Retinal Cavernous Hemangioma.</article-title>
            <source>Curr Eye Res</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>44</volume>
            <issue>4</issue>
            <fpage>423</fpage>
            <page-range>423-427</page-range>
            <pub-id pub-id-type="pmid">30433829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heimann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Damato</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Congenital vascular malformations of the retina and choroid.</article-title>
            <source>Eye (Lond)</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>3</issue>
            <fpage>459</fpage>
            <page-range>459-67</page-range>
            <pub-id pub-id-type="pmid">20019761</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shanmugam</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Ramanjulu</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Vascular tumors of the choroid and retina.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>63</volume>
            <issue>2</issue>
            <fpage>133</fpage>
            <page-range>133-40</page-range>
            <pub-id pub-id-type="pmid">25827544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Say</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SU</given-names>
              </name>
              <name>
                <surname>Ferenczy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Optical coherence tomography of retinal and choroidal tumors.</article-title>
            <source>J Ophthalmol</source>
            <year>2012</year>
            <volume>2012</volume>
            <fpage>385058</fpage>
            <pub-id pub-id-type="pmid">23008756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Labauge</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Denier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bergametti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tournier-Lasserve</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Genetics of cavernous angiomas.</article-title>
            <source>Lancet Neurol</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>237</fpage>
            <page-range>237-44</page-range>
            <pub-id pub-id-type="pmid">17303530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ravani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Optical coherence tomography of racemose angioma.</article-title>
            <source>Clin Case Rep</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>8</volume>
            <issue>7</issue>
            <fpage>1299</fpage>
            <page-range>1299-1300</page-range>
            <pub-id pub-id-type="pmid">32695379</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mansour</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Henkind</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Arteriovenous anastomoses of the retina.</article-title>
            <source>Ophthalmology</source>
            <year>1987</year>
            <month>Jan</month>
            <volume>94</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-40</page-range>
            <pub-id pub-id-type="pmid">3561955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Ophthaproblem. Retinal arteriovenous malformations (type 2).</article-title>
            <source>Can Fam Physician</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>203</fpage>
            <page-range>203, 209</page-range>
            <pub-id pub-id-type="pmid">15751561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmidt</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Agostini</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schumacher</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Twenty-seven years follow-up of a patient with congenital retinocephalofacial vascular malformation syndrome and additional congenital malformations (Bonnet-Dechaume-Blanc syndrome or Wyburn-Mason syndrome).</article-title>
            <source>Eur J Med Res</source>
            <year>2010</year>
            <month>Feb</month>
            <day>26</day>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>89</fpage>
            <page-range>89-91</page-range>
            <pub-id pub-id-type="pmid">20452891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shanmugam</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Simakurthy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Konana</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Ramanjulu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>KCD</given-names>
              </name>
            </person-group>
            <article-title>Optical coherence tomography angiography of fleeting macroaneurysm in retinal racemose angioma.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>66</volume>
            <issue>9</issue>
            <fpage>1352</fpage>
            <page-range>1352-1354</page-range>
            <pub-id pub-id-type="pmid">30127170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hajjaj</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Overdam</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Gishti</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Ramdas</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Kili&#x000e7;</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Efficacy and safety of current treatment options for peripheral retinal haemangioblastomas: a systematic review.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2022</year>
            <month>Feb</month>
            <volume>100</volume>
            <issue>1</issue>
            <fpage>e38</fpage>
            <page-range>e38-e46</page-range>
            <pub-id pub-id-type="pmid">33834636</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bornfeld</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kreusel</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>[Capillary hemangioma of the retina in cases of von Hippel-Lindau syndrome. New therapeutic directions].</article-title>
            <source>Ophthalmologe</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>104</volume>
            <issue>2</issue>
            <fpage>114</fpage>
            <page-range>114-8</page-range>
            <pub-id pub-id-type="pmid">17256181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Watzke</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Cryotherapy for retinal angiomatosis. A clinicopathologic report.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1974</year>
            <month>Nov</month>
            <volume>92</volume>
            <issue>5</issue>
            <fpage>399</fpage>
            <page-range>399-401</page-range>
            <pub-id pub-id-type="pmid">4429468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palmer</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Gragoudas</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Advances in treatment of retinal angiomas.</article-title>
            <source>Int Ophthalmol Clin</source>
            <year>1997</year>
            <season>Fall</season>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>159</fpage>
            <page-range>159-70</page-range>
            <pub-id pub-id-type="pmid">9429939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raval</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tyagi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Surgical and visual outcomes after vitreoretinal surgery for complex retinal capillary hemangioblastoma.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2023</year>
            <month>Nov</month>
            <volume>71</volume>
            <issue>11</issue>
            <fpage>3544</fpage>
            <page-range>3544-3551</page-range>
            <pub-id pub-id-type="pmid">37870022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wiley</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Krivosic</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gaudric</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gorin</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Aronow</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Chew</surname>
                <given-names>EY</given-names>
              </name>
            </person-group>
            <article-title>MANAGEMENT OF RETINAL HEMANGIOBLASTOMA IN VON HIPPEL-LINDAU DISEASE.</article-title>
            <source>Retina</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>39</volume>
            <issue>12</issue>
            <fpage>2254</fpage>
            <page-range>2254-2263</page-range>
            <pub-id pub-id-type="pmid">31259811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sachdeva</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dadgostar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kaiser</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Sears</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Verteporfin photodynamic therapy of six eyes with retinal capillary haemangioma.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>88</volume>
            <issue>8</issue>
            <fpage>e334</fpage>
            <page-range>e334-40</page-range>
            <pub-id pub-id-type="pmid">20946329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Papastefanou</surname>
                <given-names>VP</given-names>
              </name>
              <name>
                <surname>Pilli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stinghe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lotery</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>VM</given-names>
              </name>
            </person-group>
            <article-title>Photodynamic therapy for retinal capillary hemangioma.</article-title>
            <source>Eye (Lond)</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>438</fpage>
            <page-range>438-42</page-range>
            <pub-id pub-id-type="pmid">23288135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mennel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Callizo</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Combined intravitreal anti-vascular endothelial growth factor (Avastin) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>88</volume>
            <issue>5</issue>
            <fpage>610</fpage>
            <page-range>610-3</page-range>
            <pub-id pub-id-type="pmid">19222401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fallah</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brave</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Weinstock</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>GU</given-names>
              </name>
              <name>
                <surname>Bradford</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gittleman</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bloomquist</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Charlab</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hamed</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Dorff</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Chambers</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Mixter</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Dinin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pierce</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Ricks</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Donoghue</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pazdur</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Amiri-Kordestani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ibrahim</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Beaver</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors.</article-title>
            <source>Clin Cancer Res</source>
            <year>2022</year>
            <month>Nov</month>
            <day>14</day>
            <volume>28</volume>
            <issue>22</issue>
            <fpage>4843</fpage>
            <page-range>4843-4848</page-range>
            <pub-id pub-id-type="pmid">35727604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jonasch</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>McCutcheon</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Waguespack</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Wen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Tannir</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Gombos</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Fuller</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Matin</surname>
                <given-names>SF</given-names>
              </name>
            </person-group>
            <article-title>Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease.</article-title>
            <source>Ann Oncol</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>22</volume>
            <issue>12</issue>
            <fpage>2661</fpage>
            <page-range>2661-2666</page-range>
            <pub-id pub-id-type="pmid">22105611</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oudard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Elaidi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Brizard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Le Rest</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Caillet</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Deveaux</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Benoit</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Corr&#x000e9;as</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Benoudiba</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>David</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gaudric</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hammel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Joly</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Timsit</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>M&#x000e9;jean</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Richard</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group.</article-title>
            <source>Oncotarget</source>
            <year>2016</year>
            <month>Dec</month>
            <day>20</day>
            <volume>7</volume>
            <issue>51</issue>
            <fpage>85306</fpage>
            <page-range>85306-85317</page-range>
            <pub-id pub-id-type="pmid">27852035</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pili&#x000e9;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hasanov</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Matin</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Woodson</surname>
                <given-names>AHH</given-names>
              </name>
              <name>
                <surname>Marcott</surname>
                <given-names>VD</given-names>
              </name>
              <name>
                <surname>Bird</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Slack</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Fuller</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>McCutcheon</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Jonasch</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Pilot study of dovitinib in patients with von Hippel-Lindau disease.</article-title>
            <source>Oncotarget</source>
            <year>2018</year>
            <month>May</month>
            <day>04</day>
            <volume>9</volume>
            <issue>34</issue>
            <fpage>23390</fpage>
            <page-range>23390-23395</page-range>
            <pub-id pub-id-type="pmid">29805741</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jonasch</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>McCutcheon</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Gombos</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Ahrar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Perrier</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Robichaux</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Villarreal</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Weldon</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Woodson</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Pilie</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Fuller</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Waguespack</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Matin</surname>
                <given-names>SF</given-names>
              </name>
            </person-group>
            <article-title>Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial.</article-title>
            <source>Lancet Oncol</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>19</volume>
            <issue>10</issue>
            <fpage>1351</fpage>
            <page-range>1351-1359</page-range>
            <pub-id pub-id-type="pmid">30236511</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haller</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Knox</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Vitrectomy for persistent vitreous hemorrhage from a cavernous hemangioma of the optic disk.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1993</year>
            <month>Jul</month>
            <day>15</day>
            <volume>116</volume>
            <issue>1</issue>
            <fpage>106</fpage>
            <page-range>106-7</page-range>
            <pub-id pub-id-type="pmid">8328530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Japiass&#x000fa;</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Moura Brasil</surname>
                <given-names>OF</given-names>
              </name>
              <name>
                <surname>de Souza</surname>
                <given-names>EC</given-names>
              </name>
            </person-group>
            <article-title>Regression of Macular Cavernous Hemangioma with Systemic Infliximab.</article-title>
            <source>Ophthalmic Surg Lasers Imaging</source>
            <year>2010</year>
            <month>Mar</month>
            <day>09</day>
            <fpage>1</fpage>
            <page-range>1-3</page-range>
            <pub-id pub-id-type="pmid">20337337</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shanmugam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Ramanjulu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dwivedi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Barigali</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Havanje</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic surprise! Photodynamic therapy for cavernous haemangioma of the disc.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>65</volume>
            <issue>8</issue>
            <fpage>754</fpage>
            <page-range>754-757</page-range>
            <pub-id pub-id-type="pmid">28820168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rao</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Yonekawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Capone</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Peripheral Retinal Ischemia, Neovascularization, and Choroidal Infarction in Wyburn-Mason Syndrome.</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>133</volume>
            <issue>7</issue>
            <fpage>852</fpage>
            <page-range>852-4</page-range>
            <pub-id pub-id-type="pmid">25906291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turell</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Vascular tumors of the retina and choroid: diagnosis and treatment.</article-title>
            <source>Middle East Afr J Ophthalmol</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>191</fpage>
            <page-range>191-200</page-range>
            <pub-id pub-id-type="pmid">20844673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>De Potter</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Vasoproliferative tumors of the ocular fundus. Classification and clinical manifestations in 103 patients.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1995</year>
            <month>May</month>
            <volume>113</volume>
            <issue>5</issue>
            <fpage>615</fpage>
            <page-range>615-23</page-range>
            <pub-id pub-id-type="pmid">7748132</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rundle</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Peairs</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Vasoproliferative tumour of the ocular fundus associated with Waardenburg's syndrome.</article-title>
            <source>Eye (Lond)</source>
            <year>2000</year>
            <month>Feb</month>
            <volume>14 ( Pt 1)</volume>
            <fpage>105</fpage>
            <page-range>105-6</page-range>
            <pub-id pub-id-type="pmid">10755116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Clinical characters and treatments of retinal vasoproliferative tumors.</article-title>
            <source>Taiwan J Ophthalmol</source>
            <year>2016</year>
            <season>Apr-Jun</season>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>85</fpage>
            <page-range>85-88</page-range>
            <pub-id pub-id-type="pmid">29018717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Honavar</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <article-title>Retinal vasoproliferative tumor - A proposal for classification.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>66</volume>
            <issue>2</issue>
            <fpage>185</fpage>
            <page-range>185-186</page-range>
            <pub-id pub-id-type="pmid">29380753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shienbaum</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tasman</surname>
                <given-names>WS</given-names>
              </name>
            </person-group>
            <article-title>Coats disease: a lifetime disease.</article-title>
            <source>Retina</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>422</fpage>
            <page-range>422-4</page-range>
            <pub-id pub-id-type="pmid">16603961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r107">
          <label>107</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Temkar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Natarajan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Deb</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Sagar</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Exudative vascular anomalous complex-like lesion of the peripapillary area.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2024</year>
            <month>Mar</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>NP83</fpage>
            <page-range>NP83-NP86</page-range>
            <pub-id pub-id-type="pmid">37715627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r108">
          <label>108</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Querques</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kuhn</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Massamba</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Leveziel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Querques</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Souied</surname>
                <given-names>EH</given-names>
              </name>
            </person-group>
            <article-title>Perifoveal exudative vascular anomalous complex.</article-title>
            <source>J Fr Ophtalmol</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>34</volume>
            <issue>8</issue>
            <fpage>559.e1</fpage>
            <page-range>559.e1-4</page-range>
            <pub-id pub-id-type="pmid">21550688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r109">
          <label>109</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Singh</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Retinal Macroaneurysm</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">35015432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r110">
          <label>110</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bypareddy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Congenital retinal macrovessel may be associated with unilateral foveal hypoplasia/small foveal avascular zone.</article-title>
            <source>Can J Ophthalmol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>139</fpage>
            <pub-id pub-id-type="pmid">30851769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r111">
          <label>111</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bypareddy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Daggumili</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Tomar</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Optical Coherence Tomography Angiography Imaging of Congenital Retinal Macrovessel.</article-title>
            <source>Ophthalmic Surg Lasers Imaging Retina</source>
            <year>2016</year>
            <month>Oct</month>
            <day>01</day>
            <volume>47</volume>
            <issue>10</issue>
            <fpage>972</fpage>
            <page-range>972-973</page-range>
            <pub-id pub-id-type="pmid">27759867</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r112">
          <label>112</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmidt</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Natt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Neumann</surname>
                <given-names>HP</given-names>
              </name>
            </person-group>
            <article-title>Long-term results of laser treatment for retinal angiomatosis in von Hippel-Lindau disease.</article-title>
            <source>Eur J Med Res</source>
            <year>2000</year>
            <month>Feb</month>
            <day>28</day>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>47</fpage>
            <page-range>47-58</page-range>
            <pub-id pub-id-type="pmid">10720563</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r113">
          <label>113</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reich</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jaegle</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Neumann-Haefelin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Klingler</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Evers</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Daniel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bucher</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ludwig</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nuessle</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kopp</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Boehringer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Reinhard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lagr&#x000e8;ze</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Lange</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Agostini</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Genotype-phenotype correlation in von Hippel-Lindau disease.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>99</volume>
            <issue>8</issue>
            <fpage>e1492</fpage>
            <page-range>e1492-e1500</page-range>
            <pub-id pub-id-type="pmid">33720516</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r114">
          <label>114</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hudler</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Urbancic</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis.</article-title>
            <source>Genes (Basel)</source>
            <year>2022</year>
            <month>Feb</month>
            <day>17</day>
            <volume>13</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">35205407</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r115">
          <label>115</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Effron</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zakov</surname>
                <given-names>ZN</given-names>
              </name>
              <name>
                <surname>Tomsak</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Neovascular glaucoma as a complication of the Wyburn-Mason syndrome.</article-title>
            <source>J Clin Neuroophthalmol</source>
            <year>1985</year>
            <month>Jun</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>95</fpage>
            <page-range>95-8</page-range>
            <pub-id pub-id-type="pmid">2432092</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r116">
          <label>116</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reck</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Zacks</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Eibschitz-Tsimhoni</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Retinal and intracranial arteriovenous malformations: Wyburn-Mason syndrome.</article-title>
            <source>J Neuroophthalmol</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>205</fpage>
            <page-range>205-8</page-range>
            <pub-id pub-id-type="pmid">16148629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r117">
          <label>117</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hopen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Hoff</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Quencer</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The Wyburn-Mason syndrome. Concomitant chiasmal and fundus vascular malformations.</article-title>
            <source>J Clin Neuroophthalmol</source>
            <year>1983</year>
            <month>Mar</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <page-range>53-62</page-range>
            <pub-id pub-id-type="pmid">6222080</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r118">
          <label>118</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Nouri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Perez</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Treatment of retinal capillary hemangioma.</article-title>
            <source>Ophthalmology</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>109</volume>
            <issue>10</issue>
            <fpage>1799</fpage>
            <page-range>1799-806</page-range>
            <pub-id pub-id-type="pmid">12359597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r119">
          <label>119</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Joo</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Clinical and Genetic Characteristics of Retinal Capillary Hemangioblastoma in Korean Patients.</article-title>
            <source>Korean J Ophthalmol</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>36</volume>
            <issue>6</issue>
            <fpage>543</fpage>
            <page-range>543-549</page-range>
            <pub-id pub-id-type="pmid">36281577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r120">
          <label>120</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gold</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>TG</given-names>
              </name>
            </person-group>
            <article-title>Macular hole secondary to capillary hemangioblastoma.</article-title>
            <source>Optom Vis Sci</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>87</volume>
            <issue>9</issue>
            <fpage>E705</fpage>
            <page-range>E705-9</page-range>
            <pub-id pub-id-type="pmid">20601911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r121">
          <label>121</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Lanning</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Branch retinal vein obstruction secondary to retinal arteriovenous communication.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1998</year>
            <month>Sep</month>
            <volume>126</volume>
            <issue>3</issue>
            <fpage>446</fpage>
            <page-range>446-8</page-range>
            <pub-id pub-id-type="pmid">9744380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r122">
          <label>122</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoyt</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Cameron</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Racemose angioma of the mandible, face, retina, and brain: report of case.</article-title>
            <source>J Oral Surg</source>
            <year>1968</year>
            <month>Sep</month>
            <volume>26</volume>
            <issue>9</issue>
            <fpage>596</fpage>
            <page-range>596-601</page-range>
            <pub-id pub-id-type="pmid">5302209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r123">
          <label>123</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Louise M Binderup</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Smerdel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Borgwadt</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Beck Nielsen</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Madsen</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>M&#x000f8;ller</surname>
                <given-names>HU</given-names>
              </name>
              <name>
                <surname>Kiilgaard</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Friis-Hansen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Harbud</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cortnum</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Owen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gimsing</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Friis Juhl</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Munthe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Geilswijk</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>&#x000c5;K</given-names>
              </name>
              <name>
                <surname>M&#x000f8;ldrup</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Graumann</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Donskov</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gr&#x000f8;nb&#x000e6;k</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Stausb&#x000f8;l-Gr&#x000f8;n</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schaffalitzky de Muckadell</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Knigge</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Dam</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wadt</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>B&#x000f8;geskov</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bagi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lund</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Stochholm</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ousager</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Sunde</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance.</article-title>
            <source>Eur J Med Genet</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>65</volume>
            <issue>8</issue>
            <fpage>104538</fpage>
            <pub-id pub-id-type="pmid">35709961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r124">
          <label>124</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poulsen</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Gimsing</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kosteljanetz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>M&#x000f8;ller</surname>
                <given-names>HU</given-names>
              </name>
              <name>
                <surname>Brandt</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Thomsen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bisgaard</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>von Hippel-Lindau disease: surveillance strategy for endolymphatic sac tumors.</article-title>
            <source>Genet Med</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>12</issue>
            <fpage>1032</fpage>
            <page-range>1032-41</page-range>
            <pub-id pub-id-type="pmid">21912262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r125">
          <label>125</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daniels</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Chew</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Gombos</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Gorin</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Wiley</surname>
                <given-names>HE</given-names>
              </name>
            </person-group>
            <article-title>Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease.</article-title>
            <source>Ophthalmology</source>
            <year>2024</year>
            <month>May</month>
            <volume>131</volume>
            <issue>5</issue>
            <fpage>622</fpage>
            <page-range>622-633</page-range>
            <pub-id pub-id-type="pmid">38092079</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r126">
          <label>126</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Bokhari</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Al-Dhahir</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <chapter-title>Brain Cavernous Angiomas</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>28</day>
            <pub-id pub-id-type="pmid">28613621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r127">
          <label>127</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mikhail</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <chapter-title>Von Hippel-Lindau Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>1</month>
            <day>30</day>
            <pub-id pub-id-type="pmid">29083737</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140270.r128">
          <label>128</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Larcher</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Belladelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fallara</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rowe</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Capitanio</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Marandino</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Raggi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Capitanio</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Bailo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lattanzio</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Barresi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Calloni</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Barbera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Andreasi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Guazzarotti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pipitone</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Carrera</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Necchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mortini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bandello</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Falini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Partelli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Falconi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Cobelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Salonia</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians.</article-title>
            <source>Asian J Urol</source>
            <year>2022</year>
            <month>Oct</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>430</fpage>
            <page-range>430-442</page-range>
            <pub-id pub-id-type="pmid">36381595</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
